Increased Risk of Non-alcoholic Fatty Liver Disease in Low Birth Weight Individuals
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age34-49
SponsorSteno Diabetes Center Copenhagen
About this trial
The investigators recently demonstrated a increase in liver fat in early middle-aged LBW compared to normal birth weight (NBW) men, and 20% of the LBW - but none of the normal birth weight (NBW) - men had previously unknown non-alcoholic fatty liver disease (NAFLD). Here the investigators will further examine the Increased risk of non-alcoholic fatty liver disease in low birth weight individuals by performing a validation study.
Eligibility criteria
Qualifiers
250 healthy, men and women born with a low birth weight (birth weight (BW) <10% of the population) and 50 born with a normal birth weight controls (BW between 50-90% of the population)
born at term (weeks 39-41)
Disqualifiers
BMI>35 kg/m2
Disease/medication known to affect primary outcome
Self-reported high physical activity level
Alcohol intake above general recommendations.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Steno Diabetes Center Copenhagen
Lead sponsor
Aarhus University Hospital
Collaborator
Lund University
Collaborator
Source ClinicalTrials.gov